Vanda Pharmaceuticals (VNDA) Research & Development (2010 - 2026)
Vanda Pharmaceuticals (VNDA) recorded Research & Development of $36.95 million in Q2 2026, up 68.0% from $21.99 million a year earlier and up 30.0% from the prior quarter.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Research & Development (2010 - 2026) Analysis & Trends
On a TTM basis, Vanda Pharmaceuticals' Research & Development came in at $116.96 million as of Jun 30, 2026, up 24.0% year-over-year; for FY2025, it came in at $109.27 million, up 46.8% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of 14.5% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $74.43 million in FY2024 (-3.1%), $76.82 million in FY2023 (-10.4%), $85.77 million in FY2022 (+13.8%) and $75.36 million in FY2021 (+35.6%).
- The Q2 2026 figure is the highest quarterly Research & Development in data going back to Q2 2010.
- On a year-over-year basis, Research & Development rose in six of the last eight quarters, with growth averaging 26.5%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 68.8% in Q1 2025, against a decline of 33.2% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $28.44 million (Q1 2026), $29.01 million (Q4 2025) and $22.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,172.56 Bn | 1,141.15 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 637.42 Bn | 555.95 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 504.13 Bn | 477.24 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 377.81 Bn | 332.19 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 304.36 Bn | 268.35 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.51 Bn | 241.20 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 242.18 Bn | 197.58 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.29 Bn | 168.48 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 172.82 Bn | 119.47 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Vanda Pharmaceuticals | 243.62 Mn | -686.32 Mn | 46.97 Mn | 36.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.95 Mn |
| Mar 31, 2026 | 28.44 Mn |
| Dec 31, 2025 | 29.01 Mn |
| Sep 30, 2025 | 22.56 Mn |
| Jun 30, 2025 | 21.99 Mn |
| Mar 31, 2025 | 35.71 Mn |
| Dec 31, 2024 | 19.84 Mn |
| Sep 30, 2024 | 16.78 Mn |
| Jun 30, 2024 | 16.66 Mn |
| Mar 31, 2024 | 21.15 Mn |
| Dec 31, 2023 | 24.34 Mn |
| Sep 30, 2023 | 16.60 Mn |
| Jun 30, 2023 | 16.65 Mn |
| Mar 31, 2023 | 19.24 Mn |
| Dec 31, 2022 | 18.45 Mn |
| Sep 30, 2022 | 24.86 Mn |
| Jun 30, 2022 | 21.49 Mn |
| Mar 31, 2022 | 20.97 Mn |
| Dec 31, 2021 | 19.33 Mn |
| Sep 30, 2021 | 19.65 Mn |
API Access
Vanda Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();